Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Ubash3b | Rat | 1,3-dinitrobenzene | increases expression | EXP | | 6480464 | 3-dinitrobenzene results in increased expression of UBASH3B mRNA | CTD | PMID:21983209 | Ubash3b | Rat | 1-nitropyrene | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | 1-nitropyrene results in increased expression of UBASH3B mRNA | CTD | PMID:19041380 | Ubash3b | Rat | 17beta-estradiol | multiple interactions | ISO | UBASH3B (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of UBASH3B mRNA and [Estradiol co-treated with TGFB1 protein] results in increased expression of UBASH3B mRNA | CTD | PMID:20660070 and PMID:30165855 | Ubash3b | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBASH3B mRNA | CTD | PMID:32741896 | Ubash3b | Rat | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBASH3B mRNA | CTD | PMID:32741896 | Ubash3b | Rat | 2,2',5,5'-tetrachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | Ubash3b | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ubash3b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UBASH3B mRNA | CTD | PMID:19465110 | Ubash3b | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UBASH3B mRNA | CTD | PMID:33387578 and PMID:34747641 | Ubash3b | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases methylation | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased methylation of UBASH3B gene | CTD | PMID:26431795 | Ubash3b | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UBASH3B mRNA | CTD | PMID:20106945 and PMID:21632981 | Ubash3b | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of UBASH3B mRNA | CTD | PMID:30851411 | Ubash3b | Rat | 2-palmitoylglycerol | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of UBASH3B mRNA | CTD | PMID:37199045 | Ubash3b | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of UBASH3B mRNA | CTD | PMID:24780913 | Ubash3b | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of UBASH3B mRNA | CTD | PMID:31881176 | Ubash3b | Rat | aflatoxin B1 | affects expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of UBASH3B protein | CTD | PMID:20106945 | Ubash3b | Rat | aflatoxin B1 | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of UBASH3B mRNA | CTD | PMID:21632981 and PMID:27153756 | Ubash3b | Rat | all-trans-retinoic acid | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Tretinoin results in increased expression of UBASH3B mRNA | CTD | PMID:21934132 | Ubash3b | Rat | all-trans-retinoic acid | decreases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of UBASH3B mRNA | CTD | PMID:33167477 | Ubash3b | Rat | antirheumatic drug | decreases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of UBASH3B mRNA | CTD | PMID:24449571 | Ubash3b | Rat | arsenite(3-) | decreases expression | ISO | Ubash3b (Mus musculus) | 6480464 | arsenite results in decreased expression of UBASH3B mRNA | CTD | PMID:33053406 | Ubash3b | Rat | benzo[a]pyrene | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of UBASH3B mRNA | CTD | PMID:20106945 more ... | Ubash3b | Rat | benzo[a]pyrene | increases methylation | ISO | UBASH3B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of UBASH3B 3' UTR | CTD | PMID:27901495 | Ubash3b | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of UBASH3B mRNA | CTD | PMID:31199487 | Ubash3b | Rat | bisphenol A | decreases expression | ISO | Ubash3b (Mus musculus) | 6480464 | bisphenol A results in decreased expression of UBASH3B mRNA | CTD | PMID:26063408 | Ubash3b | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of UBASH3B mRNA | CTD | PMID:32145629 and PMID:34947998 | Ubash3b | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of UBASH3B gene | CTD | PMID:28505145 | Ubash3b | Rat | bisphenol A | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | bisphenol A results in increased expression of UBASH3B mRNA | CTD | PMID:27685785 | Ubash3b | Rat | Butylbenzyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of UBASH3B mRNA | CTD | PMID:31199487 | Ubash3b | Rat | carbamazepine | affects expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Carbamazepine affects the expression of UBASH3B mRNA | CTD | PMID:25979313 | Ubash3b | Rat | CGP 52608 | multiple interactions | ISO | UBASH3B (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to UBASH3B gene] | CTD | PMID:28238834 | Ubash3b | Rat | chlordecone | increases expression | ISO | Ubash3b (Mus musculus) | 6480464 | Chlordecone results in increased expression of UBASH3B mRNA | CTD | PMID:33711761 | Ubash3b | Rat | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of UBASH3B mRNA | CTD | PMID:22023808 | Ubash3b | Rat | cisplatin | decreases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of UBASH3B mRNA | CTD | PMID:27594783 | Ubash3b | Rat | cobalt dichloride | decreases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of UBASH3B mRNA | CTD | PMID:22941251 | Ubash3b | Rat | copper(II) chloride | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | cupric chloride results in increased expression of UBASH3B mRNA | CTD | PMID:38568856 | Ubash3b | Rat | copper(II) sulfate | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of UBASH3B mRNA | CTD | PMID:19549813 | Ubash3b | Rat | cyclosporin A | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of UBASH3B mRNA | CTD | PMID:20106945 and PMID:25562108 | Ubash3b | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of UBASH3B mRNA | CTD | PMID:21266533 | Ubash3b | Rat | dibutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of UBASH3B mRNA | CTD | PMID:31199487 | Ubash3b | Rat | dibutyl phthalate | increases expression | ISO | Ubash3b (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of UBASH3B mRNA | CTD | PMID:17361019 and PMID:21266533 | Ubash3b | Rat | diethyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of UBASH3B mRNA | CTD | PMID:31199487 | Ubash3b | Rat | diisobutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of UBASH3B mRNA | CTD | PMID:31199487 | Ubash3b | Rat | diisononyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of UBASH3B mRNA | CTD | PMID:31199487 | Ubash3b | Rat | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of UBASH3B mRNA | CTD | PMID:33729688 | Ubash3b | Rat | dorsomorphin | multiple interactions | ISO | UBASH3B (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Ubash3b | Rat | doxorubicin | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of UBASH3B mRNA | CTD | PMID:29803840 and PMID:30031762 | Ubash3b | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of UBASH3B mRNA | CTD | PMID:29391264 | Ubash3b | Rat | entinostat | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | entinostat results in increased expression of UBASH3B mRNA | CTD | PMID:26272509 | Ubash3b | Rat | entinostat | multiple interactions | ISO | UBASH3B (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBASH3B mRNA | CTD | PMID:27188386 | Ubash3b | Rat | epoxiconazole | decreases expression | ISO | Ubash3b (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of UBASH3B mRNA | CTD | PMID:35436446 | Ubash3b | Rat | ethanol | affects expression | ISO | Ubash3b (Mus musculus) | 6480464 | Ethanol affects the expression of UBASH3B mRNA | CTD | PMID:30319688 | Ubash3b | Rat | fulvestrant | decreases methylation | ISO | UBASH3B (Homo sapiens) | 6480464 | Fulvestrant results in decreased methylation of UBASH3B gene | CTD | PMID:31601247 | Ubash3b | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of UBASH3B mRNA | CTD | PMID:33387578 | Ubash3b | Rat | ivermectin | decreases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of UBASH3B protein | CTD | PMID:32959892 | Ubash3b | Rat | lead diacetate | decreases expression | ISO | Ubash3b (Mus musculus) | 6480464 | lead acetate results in decreased expression of UBASH3B mRNA | CTD | PMID:21829687 | Ubash3b | Rat | lead diacetate | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | lead acetate results in increased expression of UBASH3B mRNA | CTD | PMID:38568856 | Ubash3b | Rat | lead(0) | affects expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Lead affects the expression of UBASH3B mRNA | CTD | PMID:28903495 | Ubash3b | Rat | leflunomide | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | leflunomide results in increased expression of UBASH3B mRNA | CTD | PMID:28988120 | Ubash3b | Rat | methylmercury chloride | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of UBASH3B mRNA | CTD | PMID:28001369 | Ubash3b | Rat | methylparaben | decreases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | methylparaben results in decreased expression of UBASH3B mRNA | CTD | PMID:31745603 | Ubash3b | Rat | mono(2-ethylhexyl) phthalate | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of UBASH3B mRNA | CTD | PMID:36695872 | Ubash3b | Rat | nickel atom | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Nickel results in increased expression of UBASH3B mRNA | CTD | PMID:24768652 and PMID:25583101 | Ubash3b | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of UBASH3B mRNA | CTD | PMID:25729387 | Ubash3b | Rat | paracetamol | affects expression | ISO | Ubash3b (Mus musculus) | 6480464 | Acetaminophen affects the expression of UBASH3B mRNA | CTD | PMID:17562736 | Ubash3b | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of UBASH3B mRNA | CTD | PMID:33387578 | Ubash3b | Rat | paracetamol | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of UBASH3B mRNA | CTD | PMID:29067470 | Ubash3b | Rat | PCB138 | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | Ubash3b | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ubash3b (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of UBASH3B mRNA | CTD | PMID:36331819 | Ubash3b | Rat | progesterone | multiple interactions | ISO | UBASH3B (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of UBASH3B mRNA | CTD | PMID:20660070 | Ubash3b | Rat | propanal | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of UBASH3B mRNA | CTD | PMID:26079696 | Ubash3b | Rat | quercetin | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Quercetin results in increased expression of UBASH3B mRNA | CTD | PMID:21632981 | Ubash3b | Rat | rac-lactic acid | decreases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of UBASH3B mRNA | CTD | PMID:30851411 | Ubash3b | Rat | rotenone | decreases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Rotenone results in decreased expression of UBASH3B mRNA | CTD | PMID:29955902 | Ubash3b | Rat | SB 431542 | multiple interactions | ISO | UBASH3B (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Ubash3b | Rat | sodium arsenite | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of UBASH3B mRNA | CTD | PMID:34032870 and PMID:38568856 | Ubash3b | Rat | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBASH3B mRNA | CTD | PMID:32741896 | Ubash3b | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of UBASH3B mRNA | CTD | PMID:34492290 | Ubash3b | Rat | titanium dioxide | increases expression | ISO | Ubash3b (Mus musculus) | 6480464 | titanium dioxide results in increased expression of UBASH3B mRNA | CTD | PMID:23557971 | Ubash3b | Rat | titanium dioxide | decreases methylation | ISO | Ubash3b (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of UBASH3B gene and titanium dioxide results in decreased methylation of UBASH3B promoter | CTD | PMID:35295148 | Ubash3b | Rat | titanium dioxide | decreases expression | ISO | Ubash3b (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of UBASH3B mRNA | CTD | PMID:29264374 | Ubash3b | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of UBASH3B mRNA | CTD | PMID:25729387 | Ubash3b | Rat | trichostatin A | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | trichostatin A results in increased expression of UBASH3B mRNA | CTD | PMID:24935251 | Ubash3b | Rat | triphenyl phosphate | affects expression | ISO | UBASH3B (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of UBASH3B mRNA | CTD | PMID:37042841 | Ubash3b | Rat | tunicamycin | decreases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of UBASH3B mRNA | CTD | PMID:29453283 | Ubash3b | Rat | valproic acid | affects expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Valproic Acid affects the expression of UBASH3B mRNA | CTD | PMID:25979313 | Ubash3b | Rat | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of UBASH3B mRNA | CTD | PMID:29427782 | Ubash3b | Rat | valproic acid | increases methylation | ISO | UBASH3B (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of UBASH3B gene | CTD | PMID:29154799 | Ubash3b | Rat | valproic acid | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of UBASH3B mRNA | CTD | PMID:19101580 more ... | Ubash3b | Rat | valproic acid | multiple interactions | ISO | UBASH3B (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBASH3B mRNA | CTD | PMID:27188386 | Ubash3b | Rat | vinclozolin | decreases methylation | EXP | | 6480464 | vinclozolin results in decreased methylation of UBASH3B gene | CTD | PMID:30207508 and PMID:31682807 | Ubash3b | Rat | vorinostat | multiple interactions | ISO | UBASH3B (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBASH3B mRNA | CTD | PMID:27188386 | Ubash3b | Rat | vorinostat | increases expression | ISO | UBASH3B (Homo sapiens) | 6480464 | vorinostat results in increased expression of UBASH3B mRNA | CTD | PMID:26272509 | |